Document Detail


Effect of self-administered intraperitoneal bemiparin on peritoneal transport and ultrafiltration capacity in peritoneal dialysis patients with membrane dysfunction. A randomized, multi-centre open clinical trial.
MedLine Citation:
PMID:  21993377     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Progressive peritoneal membrane injury and dysfunction are feared repercussions of peritoneal dialysis (PD), and may compromise the long-term feasibility of this therapy. Different strategies have been attempted to prevent or reverse this complication with limited success.METHODS: We performed a randomized, open multi-centre trial, aimed at scrutinizing the efficacy of self-administered intraperitoneal (i.p.) bemiparin (BM) to modulate peritoneal membrane dysfunction. The main outcome variables were peritoneal creatinine transport and the ultrafiltration (UF) capacity, estimated during consecutive peritoneal equilibration tests. The trial included a control group who did not undergo intervention. The treatment phase lasted 16 weeks with a post-study follow-up of 8 weeks.RESULTS: Intraperitoneal BM did not significantly improve creatinine transport or the UF capacity, when the whole group was considered. However, we observed a time-limited improvement in the UF capacity for the subgroup of patients with overt UF failure, which was not observed in the control group. Intraperitoneal injection of BM did not carry an increased risk of peritoneal infection or major haemorrhagic complications.CONCLUSIONS: Our data do not support the systematic use of BM for management of peritoneal membrane dysfunction in PD patients. Further studies on the usefulness of this approach in patients with overt UF failure are warranted. Intraperitoneal administration of BM is safe in PD patients, provided regulated procedures are respected.
Authors:
Gloria Del Peso; M Auxiliadora Bajo; Miguel Perez Fontán; Javier Martínez; Belen Marrón; Rafael Selgas;
Related Documents :
25237987 - The effect of colloid formulation on colloid osmotic pressure in horses with naturally ...
17267677 - Basal thumb arthritis.
21611817 - The endurant stent graft system: 15-month follow-up report in patients with challenging...
25350617 - Single-plug autologous osteochondral transplantation: results at minimum 16 years' foll...
19049847 - Long-term follow-up of patients with sirolimus-eluting stents for treatment of bare-met...
11260537 - "high-dose" uva1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-12
Journal Detail:
Title:  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association     Volume:  -     ISSN:  1460-2385     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8706402     Medline TA:  Nephrol Dial Transplant     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
1Department of Nephrology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dispelling the myth: the use of renin-angiotensin blockade in atheromatous renovascular disease.
Next Document:  Is the conserved mammalian region of ZNF804A locus associated with schizophrenia? A population-based...